4//SEC Filing
Biostage, Inc. 4
Accession 0001144204-16-104051
$HRGNCIK 0001563665operating
Filed
May 22, 8:00 PM ET
Accepted
May 23, 8:00 AM ET
Size
6.7 KB
Accession
0001144204-16-104051
Insider Transaction Report
Form 4
Biostage, Inc.BSTG
McNaughton Thomas
Chief Financial Officer
Transactions
- Purchase
Common Stock
2016-05-20$1.55/sh+2,500$3,875→ 206,128 total - Purchase
Common Stock
2016-05-20$1.56/sh+2,500$3,900→ 203,628 total
Footnotes (2)
- [F1]Includes (a) a deferred stock award of 268 restricted stock units which vest on January 1, 2017; and (b) 203,360 shares of common stock held by the Reporting Person.
- [F2]Includes (a) a deferred stock award of 268 restricted stock units which vest on January 1, 2017; and (b) 205,860 shares of common stock held by the Reporting Person.
Documents
Issuer
Biostage, Inc.
CIK 0001563665
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001563665
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 8:00 AM ET
- Size
- 6.7 KB